{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:15:42Z","timestamp":1794960942119,"version":"4.9.1"},"reference-count":42,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>In order to determine genetic loci associated with decreasing risk of uterine leiomyomata (UL), a genome-wide association study (GWAS) was performed. We analyzed a group of patients with a family history of UL and a control group consisting of patients without uterine fibroids and a family predisposition to this pathology. Six significant single nucleotide polymorphisms were selected for PCR-genotyping of a large data set of patients with UL. All investigated loci (rs3020434, rs11742635, rs124577644, rs12637801, rs2861221, and rs17677069) demonstrated the lower frequency of minor alleles within a group of women with UL, especially in a subgroup consisting of patients with UL and a familial history of leiomyomata. We also found that the minor allele frequencies of these SNPs in our control group were higher than those across the Caucasian population in all. Based on the obtained data, an evaluation of the common risk of UL was performed. Further work will pave the way to create a specific SNP-panel and allow us to estimate a genotype-based leiomyoma incidence risk. Subsequent studies of genetic variability in a group of patients with a familial predisposition to UL will allow us to make the prediction of the development and course of the disease more individualized, as well as to give our patients personalized recommendations about individual reproductive strategies.<\/jats:p>","DOI":"10.3390\/biomedicines10020508","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:24:21Z","timestamp":1645475061000},"page":"508","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Familial Predisposition to Leiomyomata: Searching for Protective Genetic Factors"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-0427","authenticated-orcid":false,"given":"Maria V.","family":"Kuznetsova","sequence":"first","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly S.","family":"Sogoyan","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Donnikov","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry Y.","family":"Trofimov","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila V.","family":"Adamyan","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"},{"name":"Department of Reproductive Medicine and Surgery, Faculty of Postgraduate Education of Moscow State, University of Medicine and Dentistry, 127473 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia D.","family":"Mishina","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4383-7428","authenticated-orcid":false,"given":"Jekaterina","family":"Shubina","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry V.","family":"Zelensky","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kursk State Medical University, 305000 Kursk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady T.","family":"Sukhikh","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jogc.2019.10.031","article-title":"Influence of Ethnicity on Clinical Presentation and Quality of Life in Women with Uterine Fibroids: Results from a Prospective Observational Registry","volume":"42","author":"Murji","year":"2020","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_2","unstructured":"Adamyan, L.V. (2015). Uterine Fibroids: Diagnosis, Treatment and Rehabilitation. Clinic Recommendations."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0030-1251477","article-title":"New Directions in the Epidemiology of Uterine Fibroids","volume":"28","author":"Laughlin","year":"2010","journal-title":"Semin. Reprod. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: A systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45789-4","article-title":"Uterine leiomyomata: Etiology, symptomatology, and management","volume":"36","author":"Wallach","year":"1981","journal-title":"Fertil. Steril."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2017.09.004","article-title":"Epidemiology and Risk Factors of Uterine Fibroids","volume":"46","author":"Pavone","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jmig.2007.06.003","article-title":"Predictors of leiomyoma recurrence after laparoscopic myomectomy","volume":"14","author":"Yoo","year":"2007","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jogc.2019.01.010","article-title":"Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas\u2014An Addendum","volume":"41","author":"Laberge","year":"2019","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3892\/or.2016.5274","article-title":"Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential","volume":"37","author":"Conconi","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jog.13519","article-title":"Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy","volume":"44","author":"Kotani","year":"2018","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"V\u00e4lim\u00e4ki, N., Kuisma, H., Pasanen, A., Heikinheimo, O., Sj\u00f6berg, J., B\u00fctzow, R., Sarvilinna, N., Heinonen, H.-R., Tolvanen, J., and Bramante, S. (2018). Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability. eLife, 18.","DOI":"10.7554\/eLife.37110.047"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0020-7292(95)02533-I","article-title":"Familial predisposition to uterine leiomyomas","volume":"51","author":"Vikhlyaeva","year":"1995","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_13","first-page":"663","article-title":"Family history as a risk factor for development of uterine leiomyomas. Results of a pilot study","volume":"47","author":"Romitti","year":"2002","journal-title":"J. Reprod. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/jog.13217","article-title":"Replication of GWAS loci revealed the moderate effect of TNRC6B locus on susceptibility of Saudi women to develop uterine leiomyomas","volume":"43","author":"Bondagji","year":"2016","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/GRF.0000000000000177","article-title":"Fibroids","volume":"59","author":"Ordulu","year":"2016","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_16","first-page":"63","article-title":"Somatic mutations in MED12 gene exon 2 in women with a single uterine fibroid or multiple ones","volume":"12","author":"Sogoyan","year":"2018","journal-title":"Obst. Ginekol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/molehr\/gat083","article-title":"Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues","volume":"20","author":"Zaitseva","year":"2014","journal-title":"Mol. Hum. Reprod."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"Mehine","year":"2011","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/PGP.0000000000000255","article-title":"Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas from Russian Patients","volume":"35","author":"Osinovskaya","year":"2016","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ajabnoor, G.M.A., Mohammed, N.A., Banaganapalli, B., Abdullah, L.S., Bondagji, O.N., Mansouri, N., Sahly, N.N., Vaidyanathan, V., Bondagji, N., and Elango, R. (2018). Expanded Somatic Mutation Spectrum of MED12 Gene in Uterine Leiomyomas of Saudi Arabian Women. Front. Genet., 9.","DOI":"10.3389\/fgene.2018.00552"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Markowski, D.N., Nimzyk, R., Belge, G., L\u00f6ning, T., Helmke, B.M., and Bullerdiek, J. (2013). Molecular topography of the MED12-deleted region in smooth muscle tumors: A possible link between non-B DNA structures and hypermutability. Mol. Cytogenet., 6.","DOI":"10.1186\/1755-8166-6-23"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1038\/bjc.2014.138","article-title":"Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas","volume":"110","author":"Heinonen","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/humrep\/dey332","article-title":"Iatrogenic endometriosis harbors somatic cancer-driver mutations","volume":"34","author":"Lac","year":"2019","journal-title":"Hum. Reprod."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Munro, D., Ghersi, D., and Singh, M. (2018). Two critical positions in zinc finger domains are heavily mutated in three human cancer types. PLoS Comput. Biol., 14.","DOI":"10.1371\/journal.pcbi.1006290"},{"key":"ref_26","first-page":"1560","article-title":"Pilot investigation of the mutation profile of PIK3CA\/PTEN genes (PI3K pathway) in grade 3 endometrial cancer","volume":"41","author":"Malentacchi","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.celrep.2014.03.047","article-title":"Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity","volume":"7","author":"Turunen","year":"2014","journal-title":"Cell Rep."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Baranov, V.S., Osinovskaya, N.S., and Yarmolinskaya, M.I. (2019). Pathogenomics of Uterine Fibroids Development. Int. J. Mol. Sci., 6.","DOI":"10.37247\/PAMB.1.2020.19"},{"key":"ref_29","first-page":"225","article-title":"Lack of Association between ESR1 and CYP1A1 Gene Polymorphisms and Susceptibility to Uterine Leiomyoma in Female Patients of Iranian Descent","volume":"16","author":"Mortezaee","year":"2014","journal-title":"Cell J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ng.805","article-title":"A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids","volume":"43","author":"Cha","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Gallagher, C.S., M\u00e4kinen, N., Harris, H.R., Rahmioglu, N., Uimari, O., Cook, J.P., Shigesi, N., Ferreira, T., Velez-Edwards, D.R., and Edwards, T.L. (2019). Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis. Nat. Commun., 10.","DOI":"10.1038\/s41467-019-12536-4"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ciavattini, A., Di Giuseppe, J., Stortoni, P., Montik, N., Giannubilo, S.R., Litta, P., Islam, S., Tranquilli, A.L., Reis, F.M., and Ciarmela, P. (2013). Uterine fibroids: Pathogenesis and interactions with endometrium and endomyometrial junction. Obstet. Gynecol. Int., 2013.","DOI":"10.1155\/2013\/173184"},{"key":"ref_33","first-page":"424","article-title":"Epidemiology of Uterine Myomas: A Review","volume":"9","author":"Sparic","year":"2016","journal-title":"Int. J. Fertil. Steril."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejogrb.2019.10.014","article-title":"Clinical recurrence of submucosal myoma after a mechanical hysteroscopic myomectomy: Review after 5 years follow up","volume":"243","author":"Machancoses","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jmig.2017.07.007","article-title":"Minimally Invasive Approaches to Myoma Management","volume":"25","author":"Gingold","year":"2018","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tanos, V., Berry, K.E., Frist, M., Campo, R., and Dewilde, R.L. (2018). Prevention and Management of Complications in Laparoscopic Myomectomy. BioMed Res. Int., 2018.","DOI":"10.1155\/2018\/8250952"},{"key":"ref_37","first-page":"84","article-title":"Morcellation of occulted sarcomas during laparoscopic myomectomy and hysterectomy for patients with large fibroid uterus","volume":"70","author":"Tinelli","year":"2018","journal-title":"Minerva Ginecol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/humupd\/6.6.595","article-title":"Recurrence of leiomyomata after myomectomy","volume":"6","author":"Fauconnier","year":"2000","journal-title":"Hum. Reprod. Update"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Baretta, Z., Mocellin, S., Goldin, E., Olopade, O.I., and Huo, D. (2016). Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis. Medicine, 95.","DOI":"10.1097\/MD.0000000000004975"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ejso.2020.01.035","article-title":"Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1\/2 gene mutational status","volume":"46","author":"Gallotta","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1080\/21691401.2019.1645153","article-title":"Association between the FMR1 CGG repeat lengths and the severity of idiopathic primary ovarian insufficiency: A meta analysis","volume":"47","author":"Huang","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1515\/jpem-2018-0184","article-title":"Targeted next generation sequencing in patients with maturity-onset diabetes of the young (MODY)","volume":"31","author":"Kaya","year":"2018","journal-title":"J. Pediatr. Endocrinol. Metab."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/2\/508\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:23:54Z","timestamp":1760135034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/2\/508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["biomedicines10020508"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10020508","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]}}}